Cargando…
Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma
BACKGROUND: Altered Plastin-3 (PLS3; an actin-binding protein) expression was associated with human carcinogenesis, including pancreatic ductal adenocarcinoma (PDA). This study first assessed differentially expressed genes (DEGs) and then bioinformatically and experimentally confirmed PLS3 to be abl...
Autores principales: | Xiong, Fei, Wu, Guan-Hua, Wang, Bing, Chen, Yong-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336331/ https://www.ncbi.nlm.nih.gov/pubmed/34348730 http://dx.doi.org/10.1186/s12935-021-02117-1 |
Ejemplares similares
-
Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis
por: Chen, Ying, et al.
Publicado: (2019) -
Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose–response meta-analysis
por: Mu, Shidai, et al.
Publicado: (2018) -
Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
por: Hu, Yunfei, et al.
Publicado: (2014) -
SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population
por: Kan, Yutian, et al.
Publicado: (2018) -
RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
por: Wu, Xue, et al.
Publicado: (2022)